Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.47 |
| ▸ | CNR1 | P21554 | 8/20 | 0.47 |
| ▸ | CDC25B | P30305 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | CDC25A | P30304 | 1/20 | 0.43 |
| ▸ | CDC25C | P30307 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | DHODH | Q02127 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3572160 | 1.00 | CNR2 (0.47) | CNR2CNR1CDC25BALDH1A1CYP2C9 | |
| SCHEMBL3557963 | 0.88 | KDM4E (0.48) | CNR2CNR1CDC25BALDH1A1KDM4E | |
| SCHEMBL3557961 | 0.88 | KDM4E (0.48) | CNR2CNR1CDC25BALDH1A1KDM4E | |
| SCHEMBL3559984 | 0.87 | KDM4E (0.52) | CNR2CNR1CDC25BALDH1A1KDM4E | |
| SCHEMBL3559986 | 0.87 | KDM4E (0.52) | CNR2CNR1CDC25BALDH1A1KDM4E | |
| SCHEMBL3565370 | 0.84 | ALDH1A1 (0.46) | CNR2CNR1CDC25BALDH1A1KDM4E | |
| SCHEMBL3565366 | 0.84 | ALDH1A1 (0.46) | CNR2CNR1CDC25BALDH1A1KDM4E | |
| SCHEMBL13885625 | 0.83 | HPGD (0.47) | ALDH1A1KDM4EHPGDMEN1KMT2A | |
| SCHEMBL3562547 | 0.83 | CDC25B (0.48) | CNR2CDC25BALDH1A1KDM4ECDC25A | |
| SCHEMBL3562552 | 0.83 | CDC25B (0.48) | CNR2CDC25BALDH1A1KDM4ECDC25A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3353236-A2 | COMPOSITE PANEL MATERIAL | Cytec Industrial Materials (Derby) Limited (GB) | 2018-08-01 | — | — | EP | disclosed |
| EP-3303441-A1 | FAST CURE EPOXY RESIN COMPOSITIONS | Cytec Industrial Materials (Derby) Limited (GB) | 2018-04-11 | — | — | EP | disclosed |
| WO-2017050995-A2 | COMPOSITE PANEL MATERIAL | CYTEC INDUSTRIAL MATERIALS (DERBY) LIMITED (GB) | 2017-03-30 | — | — | WO | disclosed |
| WO-2016193821-A1 | FAST CURE EPOXY RESIN COMPOSITIONS | CYTEC INDUSTRIAL MATERIALS (DERBY) LIMITED (GB) | 2016-12-08 | — | — | WO | disclosed |
| WO-2016087603-A1 | PROCESS FOR PREPARING A MODIFIED NATURAL RUBBER BY MEANS OF A MODIFIER | COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) | 2016-06-09 | — | — | WO | disclosed |
| US-7825278-B2 | Substituted enaminones, their derivatives and uses thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-11-02 | — | — | US | disclosed |
| US-20080064748-A1 | Substituted enaminones, their derivatives and uses thereof | OXFORD FINANCE CORPORATION | 2008-03-13 | — | — | US | disclosed |
| EP-1817148-A2 | METHOD OF MAKING HIGH TEMPERATURE RESISTANT OR TOOLS | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2007-08-15 | — | — | EP | disclosed |
| EP-1742904-A4 | SUBSTITUTED ENAMINONES, THEIR DERIVATIVES AND USES THEREOF | UNIV CALIFORNIA (US) | 2007-04-18 | — | — | EP | disclosed |
| EP-1742904-A2 | SUBSTITUTED ENAMINONES, THEIR DERIVATIVES AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-01-17 | — | — | EP | disclosed |
| WO-2006024676-A2 | METHOD OF MAKING HIGH TEMPERATURE RESISTANT MODELS OR TOOLS | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2006-03-09 | — | — | WO | disclosed |
| WO-2005108347-A2 | SUBSTITUTED ENAMINONES, THEIR DERIVATIVES AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-11-17 | — | — | WO | disclosed |
| EP-1458579-A2 | METHOD OF MAKING MODELS | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2004-09-22 | — | — | EP | disclosed |
| WO-2003051649-A2 | METHOD OF MAKING MODELS | HUNTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2003-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080064748-A1 | Substituted enaminones, their derivatives and uses thereof | GABRB2, GABRB1, GABRB3 | CNR2 87/4885CNR1 78/4885CDC25B 4622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.